Search by Drug Name or NDC

    NDC 00555-0952-02 Dextroamphetamine Sulfate 5 mg/1 Details

    Dextroamphetamine Sulfate 5 mg/1

    Dextroamphetamine Sulfate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is DEXTROAMPHETAMINE SULFATE.

    Product Information

    NDC 00555-0952
    Product ID 0555-0952_e339af0f-084a-4d19-8013-3ccb826816d0
    Associated GPIs 61100020100305
    GCN Sequence Number 005011
    GCN Sequence Number Description dextroamphetamine sulfate TABLET 5 MG ORAL
    HIC3 J5B
    HIC3 Description ADRENERGICS, AROMATIC, NON-CATECHOLAMINE
    GCN 19881
    HICL Sequence Number 002065
    HICL Sequence Number Description DEXTROAMPHETAMINE SULFATE
    Brand/Generic Generic
    Proprietary Name Dextroamphetamine Sulfate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextroamphetamine Sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name DEXTROAMPHETAMINE SULFATE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
    DEA Schedule CII
    Marketing Category ANDA
    Application Number ANDA040361
    Listing Certified Through 2024-12-31

    Package

    NDC 00555-0952-02 (00555095202)

    NDC Package Code 0555-0952-02
    Billing NDC 00555095202
    Package 100 TABLET in 1 BOTTLE (0555-0952-02)
    Marketing Start Date 2001-02-12
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.51785
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DEXTROAMPHETAMINE 5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis